Risk Factors Associated with Acute Sarcopenia in Patients Hospitalized with COVID-19
Table 1
Patient demographic and clinical characteristics.
Variables
Values
Ages (M ± SD, years)
57.4 ± 15.4
Elderly (n; %)
92 (43.2)
Sex (n; %)
Female
77 (36.2)
Male
136 (63.8)
Days of signs/symptoms of prehospitalization (M; IIQ)
9 (7–11)
Signs or symptoms of prehospitalization (n; %)
Myalgia
83 (39)
Fever
118 (55.4)
Dyspnea
98 (46)
Asthenia
95 (44.6)
Anorexia
190 (89.2)
Dysgeusia/dysosmia/anosmia
71 (33.3)
Vomitus
42 (19.7)
Diarrhea
56 (26.3)
Comorbidities (n; %)
Obesity
61 (28.6)
Hypertension
98 (46)
Diabetes mellitus
57 (26.8)
Body weight (M; IIQ, kg)
84 (75–98)
Usual weight (M; IIQ, kg)
86 (78–100)
Unintentional weight loss (n; %)
193 (90.6)
Unintentional weight loss (M; IIQ, kg)
2 (2–3)
Percentage of unintentional weight loss (M; IIQ, kg)
2.7 (2.0–4.4)
Percentage of unintentional weight loss ≥3% (n; %)
83 (43)
SARC-F (M; IIQ, points)
4 (2–5)
Handgrip strength (M; IIQ, kg)
30.7 (23–37.3)
Calf circumference (M ± SD, cm)
37.1 ± 4.6
Nutritional therapy (n; %)
107 (51)
PCR levels (M; IIQ, mg/L)
94 (50–145)
LOS (M; IIQ, days)
11 (5–19)
Death (n; %)
35 (16.4)
SARC-F: strength, assistance with walking, rise from a chair, climb stairs, fall; PCR: C-reactive protein; LOS: length of stay. Statistic presented: mean and standard deviation (M + SD), number and percentage (n; %), or median and interquartile range (M; IIQ).
